Cover Image

Risk of Type 2 Diabetes Mellitus

The Special Issue “Risk of Type 2 Diabetes Mellitus: Cardiorenometabolic Syndrome and Its Components”, guest-edited by Dr. Andrej Belančić, Prof. Bojan Jelaković, and Dr. Martina Matovinović, explored the complex interrelationship between metabolic syndrome (MetS) and the global burden of type 2 dia...

Full description

Saved in:
Format: Online
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2025
Subjects:
type 2 diabetes mellitus
protein O-GlcNAcylation
glutamine fructose-6P amidotransferase
O-GlcNAc transferase
O-GlcNAcase
metabolic syndrome
pharmacological interventions
research
cardiovascular risk
ADVANCE risk score calculator
elderly
diabetes mellitus
obesity
eating patterns
binge eating
emotional eating
pharmacogenetics
pharmacokinetics
drug–drug–transporter gene interactions
drug–drug-gene interactions
lipid-lowering agents
antihypertensives
antihyperglycemics
clinical decision making
type 2
glycated hemoglobin
patient-centered care
pharmacists
population health
quality indicators
type 2 diabetes
exosomes
microRNA
biomarkers
therapy
insulin resistance
genetic susceptibility
genome-wide association study
cardiovascular outcomes
aerobic exercise
resistance training
combined training
heart rate variability
inflammatory markers
n/a
thema EDItEUR::M Medicine and Nursing
Online Access:ONIX_20250812T110751_9783725847136_594
Tags: Add Tag
No Tags, Be the first to tag this record!
Summary:The Special Issue “Risk of Type 2 Diabetes Mellitus: Cardiorenometabolic Syndrome and Its Components”, guest-edited by Dr. Andrej Belančić, Prof. Bojan Jelaković, and Dr. Martina Matovinović, explored the complex interrelationship between metabolic syndrome (MetS) and the global burden of type 2 diabetes mellitus (T2DM). This interdisciplinary collection examined how insulin resistance, dyslipidemia, central obesity, and hypertension—core components of MetS—converge to elevate the risk of T2DM and cardiovascular disease, the leading causes of morbidity and mortality worldwide. Published in Diabetology (ISSN 2673-4540), this Special Issue brought together high-quality original research articles, reviews, and communications addressing the biochemical, molecular, physiological, and clinical aspects of cardiorenometabolic syndrome. Topics included genetic susceptibility, pharmacogenetics, lifestyle interventions, diagnostic biomarkers, and emerging drug therapies, offering a comprehensive understanding of the mechanisms underlying metabolic-driven diabetes. Now compiled as a Reprint, this volume serves as a timely, authoritative resource for clinicians, researchers, and public health professionals. By synthesizing current knowledge and showcasing multidisciplinary insights, it aims to advance both clinical practice and scientific inquiry into T2DM prevention, early detection, and treatment. This Reprint stands as a valuable contribution to the ongoing efforts to mitigate the global impact of type 2 diabetes and its associated complications.

Similar Items